Wasatch Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-11,208
| Closed | -$378K | – | 238 |
|
2019
Q1 | $378K | Sell |
11,208
-84,129
| -88% | -$2.84M | ﹤0.01% | 223 |
|
2018
Q4 | $2.78M | Sell |
95,337
-978
| -1% | -$28.6K | 0.04% | 198 |
|
2018
Q3 | $5.93M | Buy |
96,315
+3,933
| +4% | +$242K | 0.07% | 156 |
|
2018
Q2 | $6.82M | Buy |
92,382
+84,017
| +1,004% | +$6.2M | 0.08% | 141 |
|
2018
Q1 | $549K | Buy |
+8,365
| New | +$549K | 0.01% | 269 |
|
2017
Q2 | – | Sell |
-3,053
| Closed | -$377K | – | 360 |
|
2017
Q1 | $377K | Hold |
3,053
| – | – | 0.01% | 332 |
|
2016
Q4 | $416K | Hold |
3,053
| – | – | 0.01% | 341 |
|
2016
Q3 | $607K | Sell |
3,053
-389
| -11% | -$77.3K | 0.01% | 326 |
|
2016
Q2 | $446K | Sell |
3,442
-115
| -3% | -$14.9K | 0.01% | 349 |
|
2016
Q1 | $312K | Buy |
3,557
+1,018
| +40% | +$89.3K | ﹤0.01% | 356 |
|
2015
Q4 | $515K | Buy |
2,539
+9
| +0.4% | +$1.83K | 0.01% | 353 |
|
2015
Q3 | $368K | Hold |
2,530
| – | – | ﹤0.01% | 353 |
|
2015
Q2 | $538K | Buy |
+2,530
| New | +$538K | 0.01% | 359 |
|